2026 Q3 - tulosraportti
9 päivää sitten
‧41 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 2 848 | ||
| 500 | ||
| 2 848 | ||
| 1 088 | ||
| 220 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 25.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q3 - tulosraportti 29.10. | ||
2026 Q2 - tulosraportti 27.8. | ||
2026 Q1 - tulosraportti 29.4. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 29.10.2025 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
·22 t sittenNew price update from Redeye today after the announcement of the rights issue price: 8.6 SEK "At SEK1 per share, the rights issue adds about 430 million new shares to the current 65.8 million, taking the total to around 496 million. Shareholders who do not take part will see their holdings diluted by about 87%. Our fundamental value of SEK10 assumes full subscription in the rights issue. It includes pro forma net cash of about SEK605m, after issuing costs of around 12%. Our relative valuation is based on peer EV multiples, and it falls to about SEK3 per share. We weight the fundamental value at 80% and the relative value at 20%, which gives a fair value of SEK8.6, rounded to SEK9."
·1 päivä sittenI do not own the stock today, but can I subscribe for new shares at 1 DKK?Yes, theoretically the TR price becomes approx. 0.2. In practice, it usually turns out that it becomes lower in an emission which is handled in this way - unless news emerge before the redemption of TR.
·1 päivä sittenStrength & power to all of us stuck in this shit sandwich. 😅 So poorly executed by management. One can only hope they have some underlying plan. Sad that this happens at the same time as the whole market is going through a really big "correction". Wishing everyone a good Friday nonetheless. 🩷
·1 päivä sittenEach existing share in BioInvent held on the record date of December 3, 2026 entitles the holder to 1 subscription right. 2 subscription rights entitle the holder to subscribe for 13 new shares. The rights issue comprises a maximum of 427,728,353 new shares. The subscription price has been set at 1.00 SEK per new share. Upon full subscription, BioInvent will raise approximately 428 MSEK before deduction of issue costs.
This was not pretty. A very costly solution to get the new share issue 100% guaranteed. The price for not being diluted is high. Wondering how a middle ground with say 60% guaranteed new share issue and a subscription price of say 10 SEK would have turned out. Perhaps they would have gotten their 430 MSEK anyway. But the risk is of course that the issue would not have been fully subscribed and they would have had to do another new share issue later. But given how this turned out, I would have preferred the latter solution. I cannot interpret the current solution in any other way than that they are desperate for cash and selling out their promising research results too cheaply.- ·1 päivä sitten · Muokattucomplete conscious action from the criminal Martin the guarantors have set as a requirement that in order for them to participate then the emi price must be brought down here then they will be involved ( then it is damn well not difficult to get it fully guaranteed ) hold your horses they have pissed on us loyal shareholders it is to cry over that some people can be so evil and totally shit on us I hope so much that something happens to the old fool he damn well shouldn't get away without it having consequences it can't be right that there aren't some large industrial enterprises that demand his head on a platter and just the fact that management themselves only participate with peanuts totally insane so my loss rose to around 250.000,- ( have close to 25.000 shares in the crap and yes know I have bought myself but based on what the old guy has said partner agreement just around the corner and data super fantastic etc.etc. )
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q3 - tulosraportti
9 päivää sitten
‧41 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·22 t sittenNew price update from Redeye today after the announcement of the rights issue price: 8.6 SEK "At SEK1 per share, the rights issue adds about 430 million new shares to the current 65.8 million, taking the total to around 496 million. Shareholders who do not take part will see their holdings diluted by about 87%. Our fundamental value of SEK10 assumes full subscription in the rights issue. It includes pro forma net cash of about SEK605m, after issuing costs of around 12%. Our relative valuation is based on peer EV multiples, and it falls to about SEK3 per share. We weight the fundamental value at 80% and the relative value at 20%, which gives a fair value of SEK8.6, rounded to SEK9."
- ·1 päivä sittenI do not own the stock today, but can I subscribe for new shares at 1 DKK?Yes, theoretically the TR price becomes approx. 0.2. In practice, it usually turns out that it becomes lower in an emission which is handled in this way - unless news emerge before the redemption of TR.
- ·1 päivä sittenStrength & power to all of us stuck in this shit sandwich. 😅 So poorly executed by management. One can only hope they have some underlying plan. Sad that this happens at the same time as the whole market is going through a really big "correction". Wishing everyone a good Friday nonetheless. 🩷
- ·1 päivä sittenEach existing share in BioInvent held on the record date of December 3, 2026 entitles the holder to 1 subscription right. 2 subscription rights entitle the holder to subscribe for 13 new shares. The rights issue comprises a maximum of 427,728,353 new shares. The subscription price has been set at 1.00 SEK per new share. Upon full subscription, BioInvent will raise approximately 428 MSEK before deduction of issue costs.This was not pretty. A very costly solution to get the new share issue 100% guaranteed. The price for not being diluted is high. Wondering how a middle ground with say 60% guaranteed new share issue and a subscription price of say 10 SEK would have turned out. Perhaps they would have gotten their 430 MSEK anyway. But the risk is of course that the issue would not have been fully subscribed and they would have had to do another new share issue later. But given how this turned out, I would have preferred the latter solution. I cannot interpret the current solution in any other way than that they are desperate for cash and selling out their promising research results too cheaply.
- ·1 päivä sitten · Muokattucomplete conscious action from the criminal Martin the guarantors have set as a requirement that in order for them to participate then the emi price must be brought down here then they will be involved ( then it is damn well not difficult to get it fully guaranteed ) hold your horses they have pissed on us loyal shareholders it is to cry over that some people can be so evil and totally shit on us I hope so much that something happens to the old fool he damn well shouldn't get away without it having consequences it can't be right that there aren't some large industrial enterprises that demand his head on a platter and just the fact that management themselves only participate with peanuts totally insane so my loss rose to around 250.000,- ( have close to 25.000 shares in the crap and yes know I have bought myself but based on what the old guy has said partner agreement just around the corner and data super fantastic etc.etc. )
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 2 848 | ||
| 500 | ||
| 2 848 | ||
| 1 088 | ||
| 220 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 25.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q3 - tulosraportti 29.10. | ||
2026 Q2 - tulosraportti 27.8. | ||
2026 Q1 - tulosraportti 29.4. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 29.10.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q3 - tulosraportti
9 päivää sitten
‧41 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q4 - tulosraportti 25.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q3 - tulosraportti 29.10. | ||
2026 Q2 - tulosraportti 27.8. | ||
2026 Q1 - tulosraportti 29.4. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 29.10.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·22 t sittenNew price update from Redeye today after the announcement of the rights issue price: 8.6 SEK "At SEK1 per share, the rights issue adds about 430 million new shares to the current 65.8 million, taking the total to around 496 million. Shareholders who do not take part will see their holdings diluted by about 87%. Our fundamental value of SEK10 assumes full subscription in the rights issue. It includes pro forma net cash of about SEK605m, after issuing costs of around 12%. Our relative valuation is based on peer EV multiples, and it falls to about SEK3 per share. We weight the fundamental value at 80% and the relative value at 20%, which gives a fair value of SEK8.6, rounded to SEK9."
- ·1 päivä sittenI do not own the stock today, but can I subscribe for new shares at 1 DKK?Yes, theoretically the TR price becomes approx. 0.2. In practice, it usually turns out that it becomes lower in an emission which is handled in this way - unless news emerge before the redemption of TR.
- ·1 päivä sittenStrength & power to all of us stuck in this shit sandwich. 😅 So poorly executed by management. One can only hope they have some underlying plan. Sad that this happens at the same time as the whole market is going through a really big "correction". Wishing everyone a good Friday nonetheless. 🩷
- ·1 päivä sittenEach existing share in BioInvent held on the record date of December 3, 2026 entitles the holder to 1 subscription right. 2 subscription rights entitle the holder to subscribe for 13 new shares. The rights issue comprises a maximum of 427,728,353 new shares. The subscription price has been set at 1.00 SEK per new share. Upon full subscription, BioInvent will raise approximately 428 MSEK before deduction of issue costs.This was not pretty. A very costly solution to get the new share issue 100% guaranteed. The price for not being diluted is high. Wondering how a middle ground with say 60% guaranteed new share issue and a subscription price of say 10 SEK would have turned out. Perhaps they would have gotten their 430 MSEK anyway. But the risk is of course that the issue would not have been fully subscribed and they would have had to do another new share issue later. But given how this turned out, I would have preferred the latter solution. I cannot interpret the current solution in any other way than that they are desperate for cash and selling out their promising research results too cheaply.
- ·1 päivä sitten · Muokattucomplete conscious action from the criminal Martin the guarantors have set as a requirement that in order for them to participate then the emi price must be brought down here then they will be involved ( then it is damn well not difficult to get it fully guaranteed ) hold your horses they have pissed on us loyal shareholders it is to cry over that some people can be so evil and totally shit on us I hope so much that something happens to the old fool he damn well shouldn't get away without it having consequences it can't be right that there aren't some large industrial enterprises that demand his head on a platter and just the fact that management themselves only participate with peanuts totally insane so my loss rose to around 250.000,- ( have close to 25.000 shares in the crap and yes know I have bought myself but based on what the old guy has said partner agreement just around the corner and data super fantastic etc.etc. )
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 2 848 | ||
| 500 | ||
| 2 848 | ||
| 1 088 | ||
| 220 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt